pindolol has been researched along with alprenolol in 172 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 117 (68.02) | 18.7374 |
| 1990's | 20 (11.63) | 18.2507 |
| 2000's | 23 (13.37) | 29.6817 |
| 2010's | 12 (6.98) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Eckelman, WC; Gibson, RE; Reba, RC; Rzeszotarski, WJ | 1 |
| Bultsma, T; Donné-Op den Kelder, GM; Rademaker, B; Timmerman, H | 1 |
| Carrupt, PA; el Tayar, N; Testa, B; Van de Waterbeemd, H | 1 |
| Carrupt, PA; Gaillard, P; Schambel, P; Testa, B | 1 |
| Artursson, P; Beigi, F; Lundahl, P; Luthman, K; Palm, K; Strandlund, G; Ungell, AL | 1 |
| Ghuloum, AM; Jain, AN; Sage, CR | 1 |
| Danelian, E; Hämäläinen, MD; Hansson, A; Karlén, A; Karlsson, R; Lennernäs, H; Löfâs, S; Winiwarter, S | 1 |
| Topliss, JG; Yoshida, F | 1 |
| Ertl, P; Rohde, B; Selzer, P | 1 |
| Artursson, P; Luthman, K; Norinder, U; Stenberg, P | 1 |
| Alvarez-Pedraglio, A; Colmenarejo, G; Lavandera, JL | 1 |
| Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 1 |
| Artursson, P; Bergström, CA; Matsson, P; Nagahara, N; Norinder, U; Tavelin, S | 1 |
| Caron, G; Ermondi, G | 1 |
| Akamatsu, M; Fujikawa, M; Nakao, K; Shimizu, R | 1 |
| Carrupt, PA; Guillarme, D; Henchoz, Y; Rudaz, S; Veuthey, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Ahman, M; Holmén, AG; Wan, H | 1 |
| Bard, B; Carrupt, PA; Martel, S | 1 |
| Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
| Du-Cuny, L; Mash, EA; Meuillet, EJ; Moses, S; Powis, G; Song, Z; Zhang, S | 1 |
| Antonsson, M; Bengtsson, O; Bredberg, U; Fridén, M; Hammarlund-Udenaes, M; Jerndal, G; Wan, H; Winiwarter, S | 1 |
| Campillo, NE; Guerra, A; Páez, JA | 1 |
| Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
| Gozalbes, R; Pineda-Lucena, A | 1 |
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Akamatsu, M | 1 |
| Ahlin, G; Bergström, F; Bredberg, U; Fridén, M; Hammarlund-Udenaes, M; Rehngren, M; Wan, H | 1 |
| Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K | 1 |
| Adams, LA; Baker, JG; Hill, SJ; Kellam, B; Middleton, RJ; Mistry, SN; Salchow, K | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Bellman, K; Knegtel, RM; Settimo, L | 1 |
| Pfeifer, S; Zimmer, C | 1 |
| Maekawa, H; Sekiya, A; Yamamoto, J | 1 |
| Miesch, F; Schwartz, J; Spach, MO | 1 |
| Scharbach, H | 1 |
| Gilman, AG; Maguire, ME; Van Arsdale, PM | 1 |
| Heinze, A; Losse, H; Wessels, F | 1 |
| Levy, JV | 1 |
| Harry, JD | 1 |
| Himori, N; Hiramatsu, Y; Ishimori, T; Izumi, A | 1 |
| Meier, J | 1 |
| Lefkowitz, RJ; Limbird, LE | 1 |
| Dickerson, DD; Fulmor, IE; Goldberg, ME; Lee, RJ | 1 |
| Day, MD; Roach, AG | 1 |
| Kiechel, JR; Meier, J | 1 |
| Tannenbaum, H | 1 |
| Drummer, O; Jarrott, B; Louis, WJ; McNeil, JJ; Rand, MJ | 1 |
| Bylund, DB; Hollenberg, MD; Tellez-Iñon, MT | 1 |
| Insel, PA; Stoolman, LM | 1 |
| Dietz, J; Kaiser, G; Palm, D; Wiemer, G | 1 |
| Bakardjieva, A; Galla, HJ; Helmreich, EJ | 1 |
| Doshchitsin, VL | 1 |
| Baker, I; Das Gupta, DS; Sowton, E | 1 |
| Boissier, JR; Giudicelli, JF; Lhoste, F | 1 |
| Meurer, KA | 1 |
| Dubach, UC | 1 |
| Frisch, P | 1 |
| Heinze, A; Werth, HW; Wessels, F | 1 |
| Henningsen, NC; Mattiasson, I | 1 |
| Himori, N; Ishimori, T; Izumi, A | 1 |
| Aellig, WH | 1 |
| Hartikainen, M; Heikkilä, J | 1 |
| Frithz, G; Nordgren, L | 1 |
| Hansson, L; Werkö, L | 1 |
| Fujita, T; Miyazaki, M; Nioka, S | 1 |
| Smith, U; Wesslau, C | 1 |
| Kompa, AR; Molenaar, P; Pak, HS; Roberts, SJ; Summers, RJ | 1 |
| Bonin, H; Bouvier, M; Frielle, T; Nantel, F; Nguyen, CT; Suzuki, T; Valiquette, M | 1 |
| Fernández-Guasti, A; Hong, E; López-Rubalcava, C | 1 |
| Ashkenazi, A; Havlik, S; Jin, H; Marsters, SA; O'Dowd, BF; Oksenberg, D; Peroutka, SJ | 1 |
| Burckhardt, G; Friedrich, T | 1 |
| Insel, PA; Jasper, JR; Michel, MC | 1 |
| Fernández-Guasti, A; López-Rubalcava, C | 1 |
| Enquist, M; Hermansson, J | 1 |
| Agmo, A; Escalante, A; Fernández-Guasti, A; Hong, E | 1 |
| Brodde, OE; Daul, A; O'Hara, N; Schiess, W; Wang, XL | 1 |
| Candelore, MR; Dixon, RA; Hill, WS; Sigal, IS; Strader, CD | 1 |
| Kellar, KJ; Stockmeier, CA | 1 |
| Korichneva, IL; Krasnikova, TL; Radiukhin, VA | 1 |
| Doggrell, SA | 1 |
| Box, RJ | 1 |
| Nagatomo, T; Tsuchihashi, H | 1 |
| Bast, A; Kramer, K; Rademaker, B; Timmerman, H | 1 |
| Affolter, H; Hertel, C; Jaeggi, K; Portenier, M; Staehelin, M | 1 |
| Borchard, U; Brodde, OE; Daul, A; O'Hara, N; Stuka, N | 1 |
| Lozinskiĭ, LG; Sandomirskiĭ, BL; Zamotaev, IP | 1 |
| Insel, PA; Mahan, LC | 1 |
| Abel, PW; May, JM; Minneman, KP | 1 |
| Fishbein, L; Jackson, CD | 1 |
| Abrahamsson, T | 1 |
| Baker, SP; Pitha, J; Raizada, MK; Sumners, C | 1 |
| Liang, BT; Molinoff, PB | 1 |
| Fozard, JR; Kidd, EJ; Neill, J; Tricklebank, MD | 1 |
| Ross, EM; Rubenstein, RC; Wong, SK | 1 |
| Insel, PA; Jasper, JR; Motulsky, HJ | 1 |
| Marsh, JD; Smith, TW | 1 |
| Homcy, CJ; Sawutz, DG; Sylvestre, D | 1 |
| Brunswick, DJ; Conway, PG; Tondo, L | 1 |
| McGonigle, P; Molinoff, PB; Neve, KA | 1 |
| Arinze, IJ; Graham, SM; Kawai, Y; Yoshioka, H | 1 |
| Bassel-Duby, R; Homcy, CJ; Sawutz, DG | 1 |
| Crooke, ST; Nakada, MT; Poksay, KS; Stadel, JM | 1 |
| Homcy, CJ; Koury, R; Sawutz, DG | 1 |
| Binkley, PF; Leier, CV; Lima, JJ; MacKichan, JJ; Shields, BJ | 1 |
| Turner, P | 1 |
| Bak, IJ; Grobecker, H; Hellenbrecht, D; Lemmer, B; Wiethold, G | 1 |
| Górka, Z | 1 |
| Gross, F | 1 |
| Grobecker, H; Hellenbrecht, D; Lemmer, B; Wiethold, G | 1 |
| Blankart, R | 1 |
| Bhargava, KP | 1 |
| Bertil, OS; Varnauskas, E | 1 |
| Hellenbrecht, D; Lemmer, B; Palm, D; Wiethold, G | 1 |
| Delbarre, B; Schmitt, H | 1 |
| Singh, BN | 1 |
| Offerhaus, L | 1 |
| Gibson, DG | 1 |
| Shand, DG | 1 |
| Prichard, BN | 1 |
| Beumer, HM | 1 |
| Furberg, CD | 1 |
| Simpson, FO | 1 |
| Baïsset, A; Montastruc, P | 1 |
| Jewitt, DE; Singh, BN | 1 |
| Cottier, P | 1 |
| Horii, D; Imai, S; Kawada, T; Takeda, K | 1 |
| Cazard, JC; Couderc, JJ; Marco, J; Salvador, M | 1 |
| Bjerle, P; Jacobsson, KA | 1 |
| Saameli, K | 1 |
| von Egidy, H | 1 |
| Combre, A; Delort, P; Duchène-Marullaz, P; Lapalus, P | 1 |
| Naess, K | 1 |
| Endoh, M; Hashimoto, K; Kimura, T | 1 |
| Brodde, OE; O'Hara, N | 1 |
| Johansson, SR; McCall, M; Vedin, JA; Wilhelmsson, C | 1 |
| Drayer, JI; Weber, MA | 1 |
| Borer, JS; Moses, JW | 1 |
| Brotelle, R; Colot, M; de Clavière, M; Heyndrickx, JP | 1 |
| Helfert, I; Mácová, S; Trcka, V; Vanĕcek, M | 1 |
| Fujimura, H; Imai, H; Niwa, M; Nozaki, M; Tsurumi, K | 1 |
| Lund-Johansen, P | 1 |
| Bengtsson, C | 1 |
| Friedewald, WT; Frishman, WH; Furberg, CD | 2 |
| Meier, KE; Ruoho, AE | 1 |
| Christoffersen, T; Jacobsen, S; Refsnes, M; Sager, G; Sand, TE; Sandnes, D; Westergren, T | 1 |
| Hashimoto, K; Kanazawa, Y; O'Hara, N; Ono, H | 1 |
| Battersby, LA; Cruickshank, JM; Prichard, BN | 1 |
| Bromberg, BB; Gregory, DS; Sears, ML | 1 |
| Haber, E; Homcy, CJ; Rockson, SG | 1 |
| England, JF | 1 |
| Auerbach, DA; Aurbach, GD; Klein, DC; Woodard, C | 1 |
| Baker, SP; Peterson, CV; Pitha, J; Posner, P | 1 |
| Storstein, L | 1 |
| Allen, LF; Apparsundaram, S; Bond, RA; Hyek, MF; Johnson, TD; Kenakin, TP; Leff, P; McMinn, TR; Milano, CA; Rockman, HA | 1 |
| Klug, S; Merker, HJ; Neubert, D; Schwabe, R; Thiel, R | 1 |
| Horton, JW; Kaufman, TM | 1 |
| Rabin, RA; Winter, JC | 1 |
| Kurose, H; Nagao, T; Sato, Y | 1 |
| Caldwell, GW; Evangelisto, M; Masucci, JA; White, R | 1 |
| Caldwell, GW; Demarest, K; Easlick, SM; Gunnet, J; Masucci, JA | 1 |
| Horinouchi, T; Koike, K | 1 |
| Haginaka, J; Sanbe, H | 1 |
| Brahmadevara, N; MacDonald, A; Shaw, AM | 1 |
| Aturki, Z; Cristalli, M; D'Orazio, G; Fanali, S; Quaglia, MG | 1 |
| Desfontis, JC; Gogny, M; Le Coz, O; Mallem, MY; Reculeau, O | 1 |
| Catabay, AP; Deñola, NL; Jinno, K; Quiming, NS; Saito, Y | 1 |
| Hu, X; Hu, Y; Li, G; Pan, J | 1 |
| Pisklak, DM; Wawer, I; Zielińska-Pisklak, MA | 1 |
| Bao, J; Johnson, PE; Krylov, SN; Krylova, SM; Reinstein, O; Wilson, DJ | 1 |
20 review(s) available for pindolol and alprenolol
| Article | Year |
|---|---|
Modeling of beta-adrenoceptors based on molecular electrostatic potential studies of agonists and antagonists.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Models, Molecular; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1988 |
[Biotransformation and pharmacokinetics of beta-receptor blockaders].
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Biotransformation; Ethanolamines; Humans; Isoproterenol; Kinetics; Levobunolol; Oxprenolol; Pindolol; Practolol; Propanolamines; Propranolol; Sotalol | 1975 |
[Beta blockers as psychotropic drugs].
Topics: Adjustment Disorders; Adrenergic beta-Antagonists; Alprenolol; Anxiety; Attention; Behavior Therapy; Delusions; Humans; Pindolol; Psychotic Disorders; Psychotropic Drugs; Receptors, Adrenergic; Sleep Wake Disorders | 1976 |
[Comparative pharmacokinetics of beta-blockers].
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Half-Life; Humans; Metoprolol; Oxprenolol; Pindolol; Practolol; Propranolol; Sotalol; Timolol | 1978 |
[Long-term utilization of beta-blockers in arterial hypertension].
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Blood Pressure; Coronary Disease; Drug Tolerance; Heart Rate; Humans; Hypertension; Metoprolol; Pindolol; Practolol; Time Factors | 1978 |
[Therapy and differential therapy with beta sympathicolytic drugs].
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Arrhythmias, Cardiac; Cardiomyopathy, Hypertrophic; Digitalis Glycosides; Drug Interactions; Ethanolamines; Humans; Hypertension; Long-Term Care; Oxprenolol; Pindolol; Propanolamines; Propranolol; Syndrome; Tachycardia | 1975 |
A toxicological review of beta-adrenergic blockers.
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Cocarcinogenesis; Ethanolamines; Female; Kinetics; Labetalol; Lethal Dose 50; Male; Metoprolol; Mice; Mutagens; Nadolol; Neoplasms, Experimental; Oxprenolol; Pindolol; Practolol; Propanolamines; Propranolol; Rats; Sotalol; Timolol | 1986 |
Beta-adrenergic receptor blocking drugs in hyperthyroidism.
Topics: Adrenergic beta-Antagonists; Alprenolol; Antithyroid Agents; Ethanolamines; Humans; Hyperthyroidism; Iodine Radioisotopes; Oxprenolol; Pindolol; Practolol; Premedication; Propranolol; Sotalol; Sympathomimetics; Thyroidectomy | 1974 |
[Clinical application of beta-blockaders].
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Anxiety Disorders; Arrhythmias, Cardiac; Cardiomyopathy, Hypertrophic; Humans; Hypertension; Hyperthyroidism; Oxprenolol; Pindolol; Practolol; Propranolol | 1973 |
Pharmacodynamic properties of beta-adrenergic receptor blocking drugs in man.
Topics: Adrenergic beta-Antagonists; Alprenolol; Blood Pressure; Cardiac Output; Catecholamines; Glycolysis; Heart; Heart Conduction System; Heart Rate; Hemodynamics; Humans; Lipid Metabolism; Oxprenolol; Oxygen Consumption; Physical Exertion; Pindolol; Practolol; Propranolol; Quinidine; Receptors, Adrenergic; Regional Blood Flow; Renin; Structure-Activity Relationship; Vasomotor System | 1974 |
Pharmacokinetic properties of the beta-adrenergic receptor blocking drugs.
Topics: Adrenergic beta-Antagonists; Adult; Alprenolol; Biopharmaceutics; Blood Proteins; Child; Half-Life; Heart Rate; Humans; Intestinal Absorption; Kinetics; Liver; Liver Circulation; Oxprenolol; Pindolol; Propranolol; Protein Binding | 1974 |
Beta-adrenergic receptor blocking drugs in angina pectoris.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Blood Pressure; Dose-Response Relationship, Drug; Drug Evaluation; Ethanolamines; Exercise Test; Heart Rate; Humans; Oxprenolol; Oxygen Consumption; Physical Exertion; Pindolol; Practolol; Propranolol; Sotalol | 1974 |
Adverse effects of beta-adrenergic receptor blocking drugs on respiratory function.
Topics: Adrenergic beta-Antagonists; Alprenolol; Asthma; Bronchi; Bronchial Spasm; Humans; Isoproterenol; Muscle, Smooth; Oxprenolol; Pindolol; Practolol; Propranolol; Respiration | 1974 |
Beta-adrenergic receptor blocking drugs in hypertrophic cardiomyopathy, autonomically mediated cardiovascular functional disorders and Fallot's tetralogy.
Topics: Adrenergic beta-Antagonists; Alprenolol; Cardiomyopathy, Hypertrophic; Cardiovascular Diseases; Drug Evaluation; Heart Rate; Humans; Oxprenolol; Pindolol; Placebos; Practolol; Propranolol; Tetralogy of Fallot | 1974 |
Beta-adrenergic receptor blocking drugs in hypertension.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Alprenolol; Antidepressive Agents; Antihypertensive Agents; Asthma; Diuretics; Drug Evaluation; Drug Therapy, Combination; Ganglionic Blockers; Heart Failure; Humans; Hypertension; Libido; Oxprenolol; Pindolol; Practolol; Propranolol; Psychopharmacology; Regional Blood Flow; Sotalol; Vasodilator Agents | 1974 |
Beta-adrenergic receptor blocking drugs in cardiac arrhythmias.
Topics: Action Potentials; Adrenergic beta-Antagonists; Alprenolol; Arrhythmia, Sinus; Arrhythmias, Cardiac; Atrial Fibrillation; Atrial Flutter; Cardiac Surgical Procedures; Catecholamines; Depression, Chemical; Digitalis Glycosides; Electrocardiography; Humans; Myocardial Infarction; Oxprenolol; Pacemaker, Artificial; Pindolol; Practolol; Propranolol; Purkinje Fibers; Tachycardia; Tachycardia, Paroxysmal; Ventricular Fibrillation; Wolff-Parkinson-White Syndrome | 1974 |
Beta-adrenergic antagonists in the treatment of patients with heart disease.
Topics: Acebutolol; Adrenergic beta-Agonists; Alprenolol; Animals; Arrhythmias, Cardiac; Bronchial Spasm; Cardiomyopathy, Hypertrophic; Coronary Disease; Female; Heart Diseases; Heart Failure; Humans; Hypertension; Metoprolol; Mitral Valve Prolapse; Mitral Valve Stenosis; Nadolol; Nervous System Diseases; Pindolol; Pregnancy; Pregnancy Complications, Cardiovascular; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Structure-Activity Relationship; Timolol | 1981 |
Beta-adrenergic blockade for survivors of acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Coronary Disease; Follow-Up Studies; Humans; Myocardial Infarction; Oxprenolol; Pindolol; Practolol; Propranolol; Sotalol; Time Factors; Timolol | 1984 |
The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Atenolol; Clinical Trials as Topic; Humans; Hypertension; Metoprolol; Myocardial Infarction; Oxprenolol; Pindolol; Practolol; Propranolol; Receptors, Adrenergic, beta; Risk; Sotalol; Timolol | 1984 |
Overdosage with beta-adrenergic blocking agents.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Alprenolol; Atropine; Blood Glucose; Cardiovascular System; Central Nervous System; Drug Tolerance; Heart Rate; Humans; Kinetics; Oxprenolol; Pindolol; Propranolol; Respiration; Sotalol | 1984 |
15 trial(s) available for pindolol and alprenolol
| Article | Year |
|---|---|
Evaluation of intrinsic sympathomimetic activity of beta-adrenoceptor blocking drugs in the treatment of patients with angina pectoris.
Topics: Acute Disease; Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Chronic Disease; Clinical Trials as Topic; Dose-Response Relationship, Drug; Exercise Test; Hemodynamics; Humans; Nitroglycerin; Pindolol; Practolol; Propranolol; Sympathomimetics | 1976 |
Clinical pharmacology of adrenergic-blocking drugs.
Topics: Adrenergic beta-Antagonists; Alprenolol; Biological Availability; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Humans; Hypertension; Pindolol; Placebos; Propranolol; Pulse; Timolol | 1979 |
Comparative effects of beta adrenergic blocking drugs.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Clinical Trials as Topic; Electrocardiography; Exercise Test; Heart Rate; Hemodynamics; Humans; Injections, Intravenous; Oxprenolol; Pindolol; Placebos; Practolol; Propranolol; Sotalol | 1975 |
[Antihypertensive therapy with a new beta-blocking agent Timolol. Double blind study and comparison with Alprenolol and Pindolol (author's transl)].
Topics: Adult; Alprenolol; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Hypertension; Male; Middle Aged; Pindolol; Propanolamines; Pulse; Renin; Timolol | 1977 |
Long-term clinical experience with atenolol--a new selective beta-1-blocker with few side-effects from the central nervous system.
Topics: Adult; Aged; Alprenolol; Atenolol; Central Nervous System; Clinical Trials as Topic; Drug Evaluation; Drug Therapy, Combination; Female; Humans; Hypertension; Male; Middle Aged; Pindolol; Propanolamines; Propranolol; Time Factors | 1979 |
Twice-daily pindolol and alprenolol in essential hypertension of moderate severity.
Topics: Administration, Oral; Adult; Alprenolol; Blood Pressure; Clinical Trials as Topic; Dose-Response Relationship, Drug; Drug Evaluation; Drug Therapy, Combination; Female; Heart Rate; Humans; Hypertension; Male; Middle Aged; Pindolol; Time Factors | 1976 |
Pindolol and alprenolol in angina pectoris: a comparative clinical study.
Topics: Administration, Oral; Adult; Aged; Alprenolol; Angina Pectoris; Clinical Trials as Topic; Exercise Test; Female; Humans; Male; Middle Aged; Nitrates; Pindolol; Placebos; Time Factors | 1975 |
Effect of propranolol, alprenolol, pindolol, and bopindolol on beta 2-adrenoceptor density in human lymphocytes.
Topics: Adult; Alprenolol; Blood Pressure; Heart Rate; Humans; Lymphocytes; Male; Pindolol; Propranolol; Receptors, Adrenergic, beta | 1986 |
[Treatment of disorders of cardiac rhythm with beta-adrenoblockaders].
Topics: Adolescent; Adrenergic beta-Antagonists; Adult; Aged; Alprenolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Female; Humans; Male; Middle Aged; Oxprenolol; Pindolol; Propanolamines; Propranolol | 1985 |
[Treatment of arterial hypertension using beta-blockaders].
Topics: Adrenergic beta-Antagonists; Alprenolol; Clinical Trials as Topic; Drug Evaluation; Humans; Hypertension; Oxprenolol; Pindolol; Practolol; Propranolol | 1974 |
Prindolol (Visken) and alprenolol (Aptin) in angina pectoris: a comparative clinical study with special reference to ergometer working capacity tests.
Topics: Adult; Aged; Alprenolol; Angina Pectoris; Blood Pressure; Clinical Trials as Topic; Electrocardiography; Exercise Test; Female; Heart Rate; Humans; Male; Middle Aged; Nitroglycerin; Pindolol; Placebos | 1974 |
Duration of action of beta blockers.
Topics: Adrenergic beta-Antagonists; Adult; Alprenolol; Atenolol; Blood Pressure; Coronary Disease; Heart Rate; Humans; Metoprolol; Penbutolol; Physical Exertion; Pindolol; Propranolol; Regression Analysis; Rest; Sotalol; Time Factors; Timolol | 1980 |
Beta-adrenergic blockade for survivors of acute myocardial infarction.
Topics: Adrenergic beta-Antagonists; Aged; Alprenolol; Arrhythmias, Cardiac; Clinical Trials as Topic; Coronary Disease; Follow-Up Studies; Humans; Myocardial Infarction; Oxprenolol; Pindolol; Practolol; Propranolol; Sotalol; Time Factors; Timolol | 1984 |
The use of beta-adrenergic blocking drugs in patients with myocardial infarction.
Topics: Adrenergic beta-Antagonists; Alprenolol; Angina Pectoris; Atenolol; Clinical Trials as Topic; Humans; Hypertension; Metoprolol; Myocardial Infarction; Oxprenolol; Pindolol; Practolol; Propranolol; Receptors, Adrenergic, beta; Risk; Sotalol; Timolol | 1984 |
The influence of beta blockers upon plasma cyclic AMP levels.
Topics: Alprenolol; Cyclic AMP; Humans; Hypertension; Middle Aged; Pindolol; Propranolol | 1980 |
139 other study(ies) available for pindolol and alprenolol
| Article | Year |
|---|---|
Cardioselectivity of beta-adrenoceptor blocking agents 1. 1-[(4-Hydroxyphenethyl)amino]-3-(aryloxy)propan-2-ols.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Binding, Competitive; Heart; In Vitro Techniques; Lung; Myocardium; Organ Specificity; Propanolamines; Rats; Receptors, Adrenergic, beta; Structure-Activity Relationship | 1979 |
Mapping of the beta 2-adrenoceptor on Chang liver cells. Differences between high- and low-affinity receptor states.
Topics: Cell Membrane; Cells, Cultured; Guanylyl Imidodiphosphate; Hydrogen Bonding; Iodocyanopindolol; Liver; Models, Molecular; Pindolol; Protein Conformation; Receptors, Adrenergic, beta; Receptors, Dopamine; Receptors, Dopamine D2; Stereoisomerism; Structure-Activity Relationship | 1988 |
Binding of arylpiperazines, (aryloxy)propanolamines, and tetrahydropyridylindoles to the 5-HT1A receptor: contribution of the molecular lipophilicity potential to three-dimensional quantitative structure-affinity relationship models.
Topics: Indoles; Ligands; Models, Molecular; Molecular Conformation; Molecular Structure; Piperazines; Propanolamines; Receptors, Serotonin; Receptors, Serotonin, 5-HT1; Serotonin; Structure-Activity Relationship; Tetrahydronaphthalenes | 1996 |
Evaluation of dynamic polar molecular surface area as predictor of drug absorption: comparison with other computational and experimental predictors.
Topics: Adrenergic beta-Antagonists; Amides; Biological Transport; Caco-2 Cells; Chromatography, Liquid; Drug Design; Epithelial Cells; Formamides; Humans; Intestinal Absorption; Liposomes; Models, Molecular; Molecular Conformation; Monte Carlo Method; Permeability; Propanolamines; Structure-Activity Relationship | 1998 |
Molecular hashkeys: a novel method for molecular characterization and its application for predicting important pharmaceutical properties of molecules.
Topics: Drug Design; Intestinal Absorption; Models, Molecular; Pharmaceutical Preparations; Structure-Activity Relationship | 1999 |
SPR biosensor studies of the direct interaction between 27 drugs and a liposome surface: correlation with fraction absorbed in humans.
Topics: Humans; Intestinal Absorption; Liposomes; Pharmaceutical Preparations; Pharmacokinetics; Predictive Value of Tests; Surface Plasmon Resonance | 2000 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties.
Topics: Biological Availability; Biological Transport; Models, Molecular; Molecular Structure; Pharmaceutical Preparations; Reproducibility of Results | 2000 |
Experimental and computational screening models for the prediction of intestinal drug absorption.
Topics: Biological Transport; Carbon Radioisotopes; Cell Line; Cell Membrane; Cell Membrane Permeability; Ciprofloxacin; Computational Biology; Drug Design; Foscarnet; Humans; Hydrogen Bonding; Intestinal Absorption; Intestinal Mucosa; Lactulose; Mannitol; Models, Biological; Raffinose; Surface Properties; Tritium; Verapamil | 2001 |
Cheminformatic models to predict binding affinities to human serum albumin.
Topics: Adrenergic beta-Antagonists; Antidepressive Agents, Tricyclic; Chromatography, Affinity; Cyclooxygenase Inhibitors; Databases, Factual; Humans; Hydrophobic and Hydrophilic Interactions; Penicillins; Pharmaceutical Preparations; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Serum Albumin; Steroids | 2001 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Exploring the role of different drug transport routes in permeability screening.
Topics: Administration, Oral; Biological Transport; Caco-2 Cells; Cell Line; Humans; Intestinal Absorption; Intestinal Mucosa; Intestine, Small; Membranes, Artificial; Models, Biological; Molecular Conformation; Monte Carlo Method; Permeability; Pharmaceutical Preparations; Pharmacokinetics | 2005 |
Calculating virtual log P in the alkane/water system (log P(N)(alk)) and its derived parameters deltalog P(N)(oct-alk) and log D(pH)(alk).
Topics: 1-Octanol; Alkanes; Hydrogen-Ion Concentration; Least-Squares Analysis; Mathematics; Models, Chemical; Models, Molecular; Solvents; Water | 2005 |
QSAR study on permeability of hydrophobic compounds with artificial membranes.
Topics: Biological Transport; Caco-2 Cells; Drug Evaluation, Preclinical; Humans; Hydrophobic and Hydrophilic Interactions; Membranes, Artificial; Permeability; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship | 2007 |
High-throughput log P determination by ultraperformance liquid chromatography: a convenient tool for medicinal chemists.
Topics: Chemical Phenomena; Chemistry, Pharmaceutical; Chemistry, Physical; Chromatography, Liquid; Mathematics; Pharmaceutical Preparations; Software | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Relationship between brain tissue partitioning and microemulsion retention factors of CNS drugs.
Topics: Brain; Central Nervous System; Chromatography, Liquid; Emulsions; Mass Spectrometry | 2009 |
Lipophilicity of basic drugs measured by hydrophilic interaction chromatography.
Topics: Chemistry, Pharmaceutical; Chromatography; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Pharmaceutical Preparations; Solubility; Technology, Pharmaceutical | 2009 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Computational modeling of novel inhibitors targeting the Akt pleckstrin homology domain.
Topics: Antineoplastic Agents; Blood Proteins; Caco-2 Cells; Cell Membrane Permeability; Computer Simulation; Drug Discovery; Drug Screening Assays, Antitumor; Humans; Models, Molecular; Phosphoproteins; Protein Binding; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-akt; Quantitative Structure-Activity Relationship | 2009 |
Structure-brain exposure relationships in rat and human using a novel data set of unbound drug concentrations in brain interstitial and cerebrospinal fluids.
Topics: Animals; Blood-Brain Barrier; Brain; Extracellular Fluid; Humans; Linear Models; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Rats; Rats, Sprague-Dawley | 2009 |
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical | 2010 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
QSAR-based solubility model for drug-like compounds.
Topics: Databases, Factual; Models, Molecular; Pharmaceutical Preparations; Quantitative Structure-Activity Relationship; Solubility; Water | 2010 |
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
Importance of physicochemical properties for the design of new pesticides.
Topics: Anabasine; Animals; Biological Availability; Cell Membrane Permeability; Chemical Phenomena; Drug Design; Humans; Imidazoles; Insecticides; Neonicotinoids; Nitro Compounds; Pesticides; Quantitative Structure-Activity Relationship; Receptors, Nicotinic | 2011 |
Measurement of unbound drug exposure in brain: modeling of pH partitioning explains diverging results between the brain slice and brain homogenate methods.
Topics: Animals; Biological Transport; Brain; Chemical Phenomena; Dialysis; Hydrogen-Ion Concentration; In Vitro Techniques; Lysosomes; Male; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Reproducibility of Results; Tissue Distribution | 2011 |
QSAR-based permeability model for drug-like compounds.
Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship | 2011 |
Synthesis and characterization of high-affinity 4,4-difluoro-4-bora-3a,4a-diaza-s-indacene-labeled fluorescent ligands for human β-adrenoceptors.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Alprenolol; Animals; Boron Compounds; CHO Cells; Cricetinae; Cricetulus; Drug Partial Agonism; Fluorescent Dyes; Genes, Reporter; Humans; Ligands; Microscopy, Confocal; Pindolol; Propranolol; Radioligand Assay; Receptors, Adrenergic, beta-1; Receptors, Adrenergic, beta-2; Receptors, Adrenergic, beta-3; Single-Cell Analysis; Stereoisomerism; Structure-Activity Relationship | 2011 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation | 2014 |
Effects of several beta-blockers on blood pressure in the rat.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Blood Pressure; Dose-Response Relationship, Drug; Epinephrine; Female; Heart Atria; Heart Rate; Male; Myocardial Contraction; Pindolol; Practolol; Propranolol; Rats | 1975 |
[Comparison of the pA2 of various beta blocking agents].
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Dose-Response Relationship, Drug; Guinea Pigs; Heart Atria; In Vitro Techniques; Oxprenolol; Pindolol; Practolol; Propranolol; Trachea | 1975 |
An agonist-specific effect of guanine nucleotides on binding to the beta adrenergic receptor.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Alprenolol; Binding Sites; Binding, Competitive; Cell Line; Epinephrine; Guanine Nucleotides; Kinetics; Pindolol; Protein Binding; Receptors, Adrenergic; Structure-Activity Relationship | 1976 |
[Therapy of hypertension using various beta receptor blockaders (timolol, alprenolol, prindolol].
Topics: Adrenergic beta-Antagonists; Alprenolol; Antihypertensive Agents; Humans; Hypertension; Pindolol | 1975 |
Beta-adrenergic receptor blocking drugs in spontaneous hypertension.
Topics: Adrenergic beta-Antagonists; Aging; Alprenolol; Animals; Blood Pressure; Hypertension; Male; Metoprolol; Oxprenolol; Pindolol; Practolol; Propanolamines; Propranolol; Pulse; Rats; Rats, Inbred Strains; Sodium Chloride; Sotalol; Stereoisomerism; Time Factors | 1976 |
Effects of beta-adrenoceptor blocking agents, pindolol, alprenolol and practolol on blood pressure and heart rate in conscious renal hypertensive dogs.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Alprenolol; Animals; Blood Pressure; Dogs; Drug Interactions; Heart Rate; Hypertension, Renal; Injections, Intravenous; Isoproterenol; Pindolol; Practolol; Propanolamines; Time Factors | 1977 |
Pindolol: a pharmacokinetic comparison with other beta-adrenoceptor blocking agents.
Topics: Adrenergic beta-Antagonists; Alprenolol; Biological Availability; Half-Life; Humans; Metoprolol; Oxprenolol; Pindolol; Practolol; Propranolol; Protein Binding; Sotalol; Timolol | 1977 |
Agonist-induced increase in apparent beta-adrenergic receptor size.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Alprenolol; Animals; Anura; Chromatography, Gel; Erythrocyte Membrane; Guanylyl Imidodiphosphate; Isoproterenol; Pindolol; Protein Conformation; Receptors, Adrenergic; Receptors, Adrenergic, beta | 1978 |
Direct myocardial depressant effects of several beta-adrenergic blocking agents in the unanesthetized atherosclerotic rabbit.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Arteriosclerosis; Atenolol; Blood Pressure; Depression, Chemical; Heart Rate; Isoproterenol; Male; Oxprenolol; Pindolol; Propanolamines; Propranolol; Rabbits; Timolol | 1978 |
The brain as a possible site for the cardiovascular effects of beta-adrenoceptor blocking agents in cats.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Blood Pressure; Brain; Cats; Female; Heart Rate; Injections, Intraventricular; Male; Oxprenolol; Pindolol; Practolol; Propranolol; Sotalol | 1975 |
Age-related parallel decline in beta-adrenergic receptors, adenylate cyclase and phosphodiesterase activity in rat erythrocyte membranes.
Topics: 3',5'-Cyclic-AMP Phosphodiesterases; Adenylyl Cyclases; Aging; Alprenolol; Animals; Benzyl Alcohols; Brain; Cell Membrane; Cytoplasm; Erythrocyte Membrane; Erythrocytes; Fluorides; Isoproterenol; Kinetics; Male; Phosphoric Diester Hydrolases; Pindolol; Rats; Receptors, Adrenergic; Receptors, Adrenergic, beta | 1977 |
Radioligand binding to beta adrenergic receptors of intact cultured S49 cells.
Topics: Alprenolol; Animals; Binding, Competitive; Cells, Cultured; Cyclic AMP; Iodine Radioisotopes; Kinetics; Mice; Pindolol; Propranolol; Receptors, Adrenergic; Receptors, Adrenergic, beta | 1978 |
Direct characterization of beta-adrenoceptors in membranes of immature red blood cells from rats.
Topics: Alprenolol; Animals; Binding Sites; Epinephrine; Erythrocyte Count; Erythrocyte Membrane; Erythrocytes; Isoproterenol; Male; Pindolol; Practolol; Propranolol; Rats; Receptors, Adrenergic; Receptors, Adrenergic, beta; Reticulocytes; Temperature; Time Factors | 1978 |
Modulation of the beta-receptor adenylate cyclase interactions in cultured Chang liver cells by phospholipid enrichment.
Topics: Adenylyl Cyclases; Alprenolol; Binding, Competitive; Cell Membrane; Cells, Cultured; Isoproterenol; Liposomes; Liver; Phospholipids; Pindolol; Receptors, Adrenergic; Receptors, Adrenergic, beta; Temperature | 1979 |
[Comparative evaluation of new drugs used in the treatment of cardiac arrhythmia].
Topics: Administration, Oral; Adrenergic beta-Antagonists; Ajmaline; Alprenolol; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Barbiturates; Drug Combinations; Drug Evaluation; Humans; Injections, Intramuscular; Injections, Intravenous; Lidocaine; Pindolol; Practolol; Propranolol; Sparteine; Verapamil | 1975 |
Beta-adrenergic blockade and atrio--ventricular conduction impairment.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Atrioventricular Node; Dogs; Electric Stimulation; Electrocardiography; Female; Heart Conduction System; Heart Rate; In Vitro Techniques; Male; Pindolol; Practolol; Propranolol; Refractory Period, Electrophysiological; Sotalol; Stereoisomerism | 1975 |
[Antihypertensive therapy using beta receptor blockers].
Topics: Adrenergic beta-Antagonists; Alprenolol; Cardiac Output; Heart Rate; Humans; Hypertension; Hypertension, Renal; Oxprenolol; Pindolol; Propranolol | 1975 |
[Editorial: Importance of cardioselectivity and sympaticomimetric potential of beta-blockers (author's transl)].
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Blood Vessels; Ethanolamines; Heart; Humans; Oxprenolol; Pindolol; Practolol; Propranolol; Sotalol; Sympathomimetics | 1975 |
Analysis of the vasodilator action of alprenolol.
Topics: Alprenolol; Animals; Blood Pressure; Dogs; Female; Heart Rate; Male; Pindolol; Practolol; Procaine; Propranolol; Vasodilator Agents | 1978 |
Activity and duration of action of pindolol and alprenolol compared in healthy volunteers.
Topics: Adult; Alprenolol; Blood Pressure; Heart Rate; Hemodynamics; Humans; Middle Aged; Physical Exertion; Pindolol; Time Factors | 1978 |
[Treatment of hypertension with beta blocking agents].
Topics: Alprenolol; Drug Therapy, Combination; Humans; Hypertension; Oxprenolol; Pindolol; Propranolol | 1975 |
[Use of various beta-adrenergic blockers in clinical anesthesia. (5) Clinical and experimental use of practolol (Eraldin)].
Topics: Adult; Alprenolol; Anesthesia, Inhalation; Animals; Arrhythmias, Cardiac; Dogs; Enflurane; Halothane; Humans; Middle Aged; Oxprenolol; Pindolol; Practolol; Propranolol | 1975 |
The inhibitory GTP-binding protein (Gi) regulates the agonistic property of beta-adrenergic ligands in isolated rat adipocytes. Evidence for a priming effect of cyclic AMP.
Topics: 1-Methyl-3-isobutylxanthine; 8-Bromo Cyclic Adenosine Monophosphate; Adenosine Diphosphate Ribose; Adenylate Cyclase Toxin; Adenylyl Cyclases; Adipose Tissue; Adrenergic beta-Agonists; Alprenolol; Animals; Cyclic AMP; GTP-Binding Proteins; Isoproterenol; Lipolysis; Male; Pertussis Toxin; Pindolol; Prenalterol; Rats; Rats, Sprague-Dawley; Terbutaline; Virulence Factors, Bordetella | 1992 |
Localization of (-)-[125I]cyanopindolol binding in guinea-pig heart: characteristics of non-beta-adrenoceptor related binding in cardiac pacemaker and conducting regions.
Topics: Alprenolol; Animals; Ascorbic Acid; Binding Sites; Ethanolamines; Female; Guinea Pigs; Haloperidol; Heart Conduction System; Isoproterenol; Male; Myocardium; Peroxidase; Phentolamine; Pindolol; Propanolamines; Propranolol; Protein Binding; Receptors, Adrenergic, beta; Serotonin; Thiophenes; Trachea | 1992 |
Distinct regulation of beta 1- and beta 2-adrenergic receptors in Chinese hamster fibroblasts.
Topics: Adenylyl Cyclases; Adrenergic beta-Antagonists; Alprenolol; Animals; Betaxolol; Binding, Competitive; Cells, Cultured; Cricetinae; Cricetulus; DNA; Down-Regulation; Epinephrine; Fibroblasts; Iodocyanopindolol; Isoproterenol; Norepinephrine; Pindolol; Propanolamines; Radioligand Assay; Receptors, Adrenergic, beta; Transfection | 1992 |
Species differences in the mechanism through which the serotonergic agonists indorenate and ipsapirone produce their anxiolytic action.
Topics: 5-Methoxytryptamine; Alprenolol; Analysis of Variance; Animals; Anti-Anxiety Agents; Behavior, Animal; Diazepam; Male; Methiothepin; Mice; Pindolol; Pyrimidines; Rats; Rats, Inbred Strains; Receptors, Serotonin; Species Specificity | 1992 |
A single amino-acid difference confers major pharmacological variation between human and rodent 5-HT1B receptors.
Topics: Alprenolol; Amino Acid Sequence; Animals; Base Sequence; Dihydroergotamine; Humans; In Vitro Techniques; Methiothepin; Methysergide; Mice; Molecular Sequence Data; Pindolol; Propranolol; Rats; Receptors, Serotonin; Serotonin; Serotonin Receptor Agonists | 1992 |
Inhibition of the rat renal Na+/H+ exchanger by beta-adrenergic antagonists.
Topics: Adrenergic beta-Antagonists; Alprenolol; Amiloride; Animals; Carrier Proteins; Dicyclohexylcarbodiimide; Dose-Response Relationship, Drug; Kidney Cortex; Kinetics; Microvilli; Pindolol; Propranolol; Protein Binding; Rats; Sodium-Hydrogen Exchangers | 1991 |
Partial agonistic activity of two irreversible beta-adrenergic receptor ligands, bromoacetylated derivatives of alprenolol and pindolol.
Topics: Adrenergic beta-Agonists; Alprenolol; Cell Line; Colforsin; Cyclic AMP; Cyclohexane Monoterpenes; Dose-Response Relationship, Drug; Humans; Pindolol | 1991 |
Evidence for the involvement of the 5-HT1A receptor in the anxiolytic action of indorenate and ipsapirone.
Topics: 5-Methoxytryptamine; Alprenolol; Animals; Anti-Anxiety Agents; Antihypertensive Agents; Diazepam; Exploratory Behavior; Male; Methiothepin; Mice; Motor Activity; Pindolol; Pyrimidines; Receptors, Serotonin; Serotonin | 1990 |
Separation of the enantiomers of beta-receptor blocking agents and other cationic drugs using a CHIRAL-AGP column. Binding properties and characterization of immobilized alpha 1-acid glycoprotein.
Topics: Adrenergic beta-Antagonists; Adsorption; Alprenolol; Atenolol; Binding Sites; Butylamines; Chromatography; Metoprolol; Molecular Structure; Orosomucoid; Oxprenolol; Pindolol; Propranolol; Protein Conformation; Spectrometry, Fluorescence; Stereoisomerism | 1990 |
Behavioural actions of the serotonergic anxiolytic indorenate.
Topics: 5-Methoxytryptamine; Alprenolol; Animals; Anti-Anxiety Agents; Behavior, Animal; Dose-Response Relationship, Drug; Fenclonine; Male; Pindolol; Psychomotor Performance; Rats; Rats, Inbred Strains; Receptors, Serotonin; Sexual Behavior, Animal; Single-Blind Method | 1990 |
Identification of two serine residues involved in agonist activation of the beta-adrenergic receptor.
Topics: Adenylyl Cyclases; Alprenolol; Amino Acid Sequence; Animals; Cell Line; Cell Membrane; Iodocyanopindolol; Isoproterenol; Kinetics; Ligands; Molecular Sequence Data; Mutation; Pindolol; Receptors, Adrenergic, beta; Serine; Structure-Activity Relationship | 1989 |
Serotonin depletion unmasks serotonergic component of [3H]dihydroalprenolol binding in rat brain.
Topics: 5,7-Dihydroxytryptamine; 8-Hydroxy-2-(di-n-propylamino)tetralin; Alprenolol; Animals; Brain; Dihydroalprenolol; Fenclonine; In Vitro Techniques; Iodocyanopindolol; Male; p-Chloroamphetamine; Pindolol; Piperazines; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Receptors, Serotonin; Serotonin; Tetrahydronaphthalenes | 1989 |
[Dependence of kinetic constants of intact human lymphocyte beta2-adrenoreceptors on the nature of the radioligands used].
Topics: Adrenergic beta-Antagonists; Alprenolol; Binding, Competitive; Ethylmaleimide; Humans; Isoproterenol; Kinetics; Lymphocytes; Pindolol; Propanolamines; Radioligand Assay; Receptors, Adrenergic, beta; Temperature | 1989 |
The effects of beta-adrenoreceptor antagonists on the force responses of the electrically driven rat right ventricle strip to isoprenaline.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Electric Stimulation; Heart; In Vitro Techniques; Isoproterenol; Male; Metoprolol; Myocardial Contraction; Pindolol; Propanolamines; Rats; Rats, Inbred Strains | 1989 |
Quantitative comparison of bromoacetylated derivatives of alprenolol and pindolol on beta-adrenergic receptor binding and mobility in S49 cells.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Cell Membrane; Cyclohexane Monoterpenes; Lipoproteins, LDL; Mice; Pindolol; Receptors, Adrenergic, beta; Transferrin; Tumor Cells, Cultured | 1989 |
Effects of choline and inositol on 3H-dihydroalprenolol and 125I-iodocyanopindolol bindings to beta-adrenergic receptors of the guinea pig cerebral cortical membranes.
Topics: Alprenolol; Animals; Cerebral Cortex; Choline; Dihydroalprenolol; Guinea Pigs; In Vitro Techniques; Inositol; Iodocyanopindolol; Male; Pindolol; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta | 1988 |
Irreversible binding of the fluorescent beta-adrenoceptor probes alprenolol-NBD and pindolol-NBD to specific and non-specific binding sites.
Topics: 4-Chloro-7-nitrobenzofurazan; Alprenolol; Animals; Cell Line; Fluorescent Dyes; Guinea Pigs; Heart; Heart Atria; In Vitro Techniques; Isoproterenol; Liver; Muscle, Smooth; Myocardium; Oxadiazoles; Pindolol; Receptors, Adrenergic, beta; Trachea | 1988 |
(-)-S-[3H]CGP-12177 and its use to determine the rate constants of unlabeled beta-adrenergic antagonists.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Cell Line; Computers; Glioma; Kinetics; Pindolol; Propanolamines; Stereoisomerism | 1985 |
Effects of beta-adrenoceptor antagonist administration on beta 2-adrenoceptor density in human lymphocytes. The role of the "intrinsic sympathomimetic activity".
Topics: Adrenergic beta-Antagonists; Adult; Alprenolol; Animals; Humans; Lymphocytes; Male; Pindolol; Propranolol; Rats; Receptors, Adrenergic, beta; Sympathomimetics | 1985 |
Expression of beta-adrenergic receptors in synchronous and asynchronous S49 lymphoma cells. I. Receptor metabolism after irreversible blockade of receptors and in cells traversing the cell division cycle.
Topics: Adrenergic beta-Antagonists; Alprenolol; Cell Cycle; Cell Division; Cell Line; Centrifugation; Humans; Iodine Radioisotopes; Iodocyanopindolol; Isoproterenol; Lymphoma; Pindolol; Receptors, Adrenergic, beta | 1986 |
Binding of agonists and antagonists to beta-adrenoceptors in rat vas deferens: relationship to functional response.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Alprenolol; Animals; Isoproterenol; Male; Pindolol; Rats; Receptors, Adrenergic, beta; Vas Deferens | 1985 |
The beta 1- and beta 2-adrenoceptor stimulatory effects of alprenolol, oxprenolol and pindolol: a study in the isolated right atrium and uterus of the rat.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Alprenolol; Animals; Female; Heart; Heart Atria; In Vitro Techniques; Isoproterenol; Male; Oxprenolol; Pindolol; Practolol; Propanolamines; Rats; Rats, Inbred Strains; Uterus | 1986 |
Characteristics of the beta-adrenoreceptor from neuronal and glial cells in primary cultures of rat brain.
Topics: Adrenergic beta-Agonists; Alprenolol; Animals; Animals, Newborn; Binding, Competitive; Brain; Cell Membrane; Cells, Cultured; Cyclic AMP; Cycloheximide; Iodine Radioisotopes; Iodocyanopindolol; Isoproterenol; Kinetics; Neuroglia; Neurons; Pindolol; Rats; Receptors, Adrenergic, beta | 1986 |
Beta adrenergic receptor subtypes in the atria: evidence for close coupling of beta-1 and beta-2 adrenergic receptors to adenylate cyclase.
Topics: Adenylyl Cyclases; Adrenergic beta-Antagonists; Alprenolol; Animals; Computers; Dogs; Dose-Response Relationship, Drug; Heart Atria; In Vitro Techniques; Iodine Radioisotopes; Isoproterenol; Myocardium; Norepinephrine; Pindolol; Receptors, Adrenergic, beta | 1986 |
Mediation of the discriminative stimulus properties of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT) by the putative 5-HT1A receptor.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Adrenergic alpha-Agonists; Adrenergic alpha-Antagonists; Alprenolol; Animals; Buspirone; Discrimination Learning; Dose-Response Relationship, Drug; Generalization, Psychological; Male; Naphthalenes; Pindolol; Pyrimidines; Rats; Rats, Inbred Strains; Receptors, Serotonin; Tetrahydronaphthalenes | 1987 |
The hydrophobic tryptic core of the beta-adrenergic receptor retains Gs regulatory activity in response to agonists and thiols.
Topics: Adrenergic beta-Agonists; Alprenolol; Animals; Chromatography, Affinity; GTP-Binding Proteins; Guanosine 5'-O-(3-Thiotriphosphate); Guanosine Triphosphate; Iodocyanopindolol; Peptide Mapping; Pindolol; Rabbits; Receptors, Adrenergic, beta; Sulfhydryl Compounds; Thionucleotides; Time Factors; Trypsin | 1987 |
Characterization of a bromoacetylated derivative of pindolol as a high affinity, irreversible beta adrenergic antagonist in cultured cells.
Topics: Adrenergic beta-Antagonists; Alprenolol; Alprostadil; Animals; Cyclic AMP; Cyclohexane Monoterpenes; Dose-Response Relationship, Drug; Iodocyanopindolol; Membrane Proteins; Mice; Pindolol; Receptors, Adrenergic, beta; Tumor Cells, Cultured | 1988 |
Receptors for beta-adrenergic agonists in cultured chick ventricular cells. Relationship between agonist binding and physiologic effect.
Topics: Alprenolol; Animals; Cells, Cultured; Chick Embryo; Guanylyl Imidodiphosphate; Heart Ventricles; Isoproterenol; Kinetics; Myocardial Contraction; Myocardium; Pindolol; Propranolol; Receptors, Adrenergic, beta | 1985 |
Characterization of monoclonal antibodies to the beta-adrenergic antagonist alprenolol as models of the receptor binding site.
Topics: Alprenolol; Animals; Antibodies, Monoclonal; Ascitic Fluid; Binding Sites, Antibody; Binding, Competitive; Dihydroalprenolol; Hybridomas; Iodocyanopindolol; Mice; Models, Biological; Pindolol; Receptors, Adrenergic, beta | 1985 |
Labeling in vivo of beta adrenergic receptors in the central nervous system of the rat after administration of [125I] iodopindolol.
Topics: Alprenolol; Animals; Betaxolol; Binding, Competitive; Brain Stem; Central Nervous System; Cerebellum; Cerebral Cortex; Clenbuterol; Isotope Labeling; Male; Mathematics; Pindolol; Propanolamines; Propranolol; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta; Spinal Cord; Tissue Distribution | 1985 |
Quantitative analysis of the selectivity of radioligands for subtypes of beta adrenergic receptors.
Topics: Alprenolol; Animals; Cell Line; Dihydroalprenolol; Dose-Response Relationship, Drug; Glioma; Heart Atria; Humans; Iodocyanopindolol; Kinetics; Mathematics; Pindolol; Receptors, Adrenergic, beta; Software | 1986 |
Beta-adrenergic receptors in guinea-pig liver plasma membranes and thermal lability of [3H]dihydroalprenolol binding sites.
Topics: Adenosine Diphosphate Ribose; Adenylate Cyclase Toxin; Alprenolol; Animals; Binding, Competitive; Cell Membrane; Cholera Toxin; Dihydroalprenolol; Guanylyl Imidodiphosphate; Guinea Pigs; Hot Temperature; Iodocyanopindolol; Isoproterenol; Liver; Male; Pindolol; Propanolamines; Receptors, Adrenergic, beta; Virulence Factors, Bordetella | 1986 |
High affinity binding of reovirus type 3 to cells that lack beta adrenergic receptor activity.
Topics: Adenylyl Cyclases; Alprenolol; Animals; Binding, Competitive; Cell Line; Iodocyanopindolol; Isoproterenol; Mammalian orthoreovirus 3; Pindolol; Radioligand Assay; Receptors, Adrenergic, beta; Receptors, Virus; Reoviridae | 1987 |
Glucocorticoid regulation of beta-adrenergic receptors in 3T3-L1 preadipocytes.
Topics: Adipose Tissue; Alprenolol; Animals; Binding, Competitive; Cell Line; Colforsin; Cyclic AMP; Cycloheximide; Dactinomycin; Dexamethasone; Epinephrine; Glucocorticoids; Iodocyanopindolol; Kinetics; Membranes; Mice; Norepinephrine; Pindolol; Receptors, Adrenergic, beta; Tunicamycin | 1987 |
Enhanced antigen-antibody binding affinity mediated by an anti-idiotypic antibody.
Topics: Alprenolol; Animals; Antibodies, Monoclonal; Antigen-Antibody Complex; Immunoglobulin Fab Fragments; Immunoglobulin G; Immunoglobulin Idiotypes; Iodocyanopindolol; Kinetics; Pindolol; Rabbits; Thermodynamics | 1987 |
Determination of pindolol in human plasma and urine by high-performance liquid chromatography with ultraviolet detection.
Topics: Alprenolol; Chromatography, High Pressure Liquid; Humans; Indicators and Reagents; Kinetics; Pindolol; Spectrophotometry, Ultraviolet | 1986 |
Human blood platelets as cellular models for investigation of membrane active drugs: beta-adrenergic blocking agents.
Topics: Adrenergic beta-Antagonists; Alprenolol; Amino Alcohols; Biological Transport; Blood Platelets; Carbon Isotopes; Cell Membrane Permeability; Humans; Kinetics; Microscopy, Electron; Models, Biological; Oxprenolol; Pindolol; Propranolol; Serotonin; Serotonin Antagonists; Sotalol; Tritium | 1972 |
Analysis of the hemodynamic action of beta-adrenolytics in narcotized cats.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Cats; Chemical Phenomena; Chemistry; Female; Hemodynamics; Male; Oxprenolol; Pindolol; Propranolol; Sotalol | 1973 |
[Current drugs. Therapy using -blockaders ( -adrenolytics)].
Topics: Acetanilides; Adrenergic beta-Antagonists; Alprenolol; Amino Alcohols; Angina Pectoris; Arrhythmias, Cardiac; Asthma; Ergoloid Mesylates; Humans; Hypertension; Oxprenolol; Pindolol; Propranolol; Propylamines | 1973 |
Measurement of hydrophobicity, surface activity, local anaesthesia, and myocardial conduction velocity as quantitative parameters of the non-specific membrane affinity of nine -adrenergic blocking agents.
Topics: 1-Propanol; Absorption; Acetanilides; Adrenergic beta-Antagonists; Alprenolol; Amino Alcohols; Anesthetics, Local; Animals; Anura; Butylamines; Cresols; Ethanolamines; Heart Conduction System; In Vitro Techniques; Membranes; Nitrobenzenes; Oxprenolol; Phenethylamines; Phenols; Pindolol; Propranolol; Propylamines; Sotalol; Structure-Activity Relationship; Surface Tension; Surface-Active Agents; Water | 1973 |
[Basis for the use of beta-receptor blockaders in the practice].
Topics: Acetanilides; Adrenergic beta-Antagonists; Alprenolol; Amino Alcohols; Humans; Oxprenolol; Pindolol; Propranolol; Propylamines; Sympathetic Nervous System | 1973 |
On the importance of a central beta-adrenoceptor site in the antiarrhythmic activity of beta-blockers.
Topics: Aconitum; Adrenal Glands; Adrenergic beta-Antagonists; Alprenolol; Animals; Arrhythmias, Cardiac; Catecholamines; Coronary Vessels; Dogs; Hypothalamus; Pentylenetetrazole; Picrotoxin; Pindolol; Propranolol; Receptors, Drug | 1972 |
A preliminary report on the duration of beta-blockade after oral intake of L-B46.
Topics: Administration, Oral; Adrenergic beta-Agonists; Alprenolol; Blood Pressure; Electrocardiography; Heart Rate; Humans; Isoproterenol; Male; Pindolol; Pulse; Time Factors | 1972 |
Membrane effects of beta-adrenergic blocking agents: investigations with the fluorescence probe 1-anilino-8-naphthalene sulfonate (ANS) and antihemolytic activities.
Topics: Adrenergic beta-Antagonists; Alprenolol; Amino Alcohols; Aniline Compounds; Binding Sites; Blood Proteins; Dose-Response Relationship, Drug; Erythrocytes; Hemolysis; Humans; In Vitro Techniques; Membranes; Naphthalenes; Pindolol; Propranolol; Sotalol; Spectrometry, Fluorescence; Sulfonic Acids | 1973 |
A further attempt to characterize sedative receptors activated by clonidine in chickens and mice.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Alprenolol; Animals; Chickens; Chloral Hydrate; Clonidine; Female; Hypnotics and Sedatives; Isoproterenol; Mice; Moxisylyte; Pindolol; Receptors, Drug; Reflex; Sleep; Yohimbine | 1973 |
Clinical aspects of the anti-arrhythmic actions of beta-receptor blocking drugs. 2. Clinical pharmacology.
Topics: Adrenergic beta-Antagonists; Alprenolol; Arrhythmias, Cardiac; Drug Therapy, Combination; Heart Failure; Humans; Oxprenolol; Pindolol; Practolol; Propranolol; Quinidine; Stereoisomerism; Structure-Activity Relationship | 1973 |
[Effects of various adrenergic beta receptor blockers on hypertensive reflexes induced by the stimulation of neural afferences].
Topics: Adrenergic beta-Antagonists; Alprenolol; Anesthesia, General; Animals; Blood Pressure; Butoxamine; Dogs; Electric Stimulation; Gallamine Triethiodide; Pindolol; Practolol; Propranolol; Reflex | 1974 |
Comparison of beta-adrenergic blocking activities of propranolol, isopropylmethoxamine, sotalol, practolol, alprenolol, pindolol, oxprenolol and D-32 in the atria and trachea of the guinea-pig.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Butylamines; Dose-Response Relationship, Drug; Electric Stimulation; Female; Guinea Pigs; Heart Atria; Heart Rate; In Vitro Techniques; Male; Methoxamine; Muscle Contraction; Muscle, Smooth; Oxprenolol; Phenyl Ethers; Pindolol; Practolol; Propanolamines; Propranolol; Receptors, Drug; Sotalol; Trachea | 1974 |
Beta-blockade for hypertension.
Topics: Adrenergic beta-Antagonists; Alprenolol; Antihypertensive Agents; Humans; Hypertension; Oxprenolol; Pindolol; Propranolol | 1974 |
[Beta-adrenergic inhibitors (pharmacologic data and deductions for therapeutic application)].
Topics: Adrenergic beta-Antagonists; Alprenolol; Biopharmaceutics; Heart; Humans; Oxygen Consumption; Pindolol; Practolol; Propranolol | 1973 |
Pharmacological characterisation of -receptor blocking agents.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Cats; Ethanolamines; Guinea Pigs; Heart Rate; Isoproterenol; Pindolol; Propranolol; Sotalol | 1972 |
[What is assured in treatment with beta receptor blockaders?].
Topics: Acetanilides; Adrenergic beta-Antagonists; Alprenolol; Amino Alcohols; Cresols; Heart Diseases; Humans; Hypertension; Isoproterenol; Oxprenolol; Parkinson Disease; Pheochromocytoma; Pindolol; Propranolol; Propylamines; Structure-Activity Relationship | 1972 |
[Nycthemeral variation in the cardiac frequency of dogs with chronic auriculo-ventricular dissociation. Role of extrinsic cardiac innervation].
Topics: Alprenolol; Animals; Atropine; Dogs; Heart Conduction System; Heart Rate; Periodicity; Pindolol; Propranolol | 1972 |
[A beta blocking agent as an antihypertensive agent].
Topics: Aged; Alprenolol; Drug Evaluation; Female; Humans; Hypertension; Male; Middle Aged; Pindolol; Practolol; Propranolol | 1973 |
Effects of perivascular nerve stimulation on the contraction and automaticity of the blood-perfused canine papillary muscle.
Topics: Alprenolol; Animals; Atropine; Cocaine; Dogs; Electric Stimulation; Female; Guanethidine; Hexamethonium Compounds; In Vitro Techniques; Male; Muscle Contraction; Norepinephrine; Papillary Muscles; Perfusion; Pindolol; Propranolol; Reserpine; Tetrodotoxin | 1972 |
Identical binding properties of (+/-)- and (-)-125Iodocyanopindolol to beta 2-adrenoceptors in intact human lymphocytes.
Topics: Alprenolol; Binding Sites; Cell Membrane; Humans; In Vitro Techniques; Iodine Radioisotopes; Iodocyanopindolol; Isoproterenol; Kinetics; Lymphocytes; Pindolol; Propranolol; Receptors, Adrenergic, beta | 1984 |
Renal effects of beta-adrenoceptor blockade.
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Angiotensin II; Animals; Blood Pressure; Cardiac Output; Glomerular Filtration Rate; Humans; Hypertension; Kidney; Pindolol; Propranolol; Renin; Sodium | 1980 |
Variability in the preventive action of the B-blockers on genetic hypertension in the rat.
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Blood Pressure; Dose-Response Relationship, Drug; Hypertension; Male; Metoprolol; Oxprenolol; Pindolol; Practolol; Propranolol; Rats; Rats, Inbred Strains; Species Specificity; Time Factors | 1980 |
A comparative study of the effects of metipranolol, propranolol, alprenolol, oxprenolol, pindolol and practolol on the circulation in experimental animals.
Topics: Alprenolol; Animals; Blood Circulation; Cats; Dogs; Female; Guinea Pigs; Heart Rate; Male; Metipranolol; Oxprenolol; Pindolol; Practolol; Propanolamines; Propranolol | 1980 |
[Influence of indomethacin and clidanac on the blood pressure lowering effect of beta-blockers].
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Blood Pressure; Dihydroalprenolol; Drug Interactions; Guinea Pigs; Heart Rate; In Vitro Techniques; Indans; Indenes; Indomethacin; Injections, Intravenous; Male; Pindolol; Propranolol; Rabbits; Radioligand Assay; Receptors, Adrenergic, beta | 1983 |
Central haemodynamic effects of beta blockers in hypertension. A comparison between atenolol, metoprolol, timolol, penbutolol, alprenolol pindolol and bunitrolol.
Topics: Adrenergic beta-Antagonists; Alprenolol; Atenolol; Hemodynamics; Humans; Hypertension; Metoprolol; Pindolol; Propanolamines; Time Factors; Timolol | 1983 |
Impairment of physical performance after treatment with beta blockers and alpha blockers.
Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Alprenolol; Heart Rate; Humans; Hydrochlorothiazide; Labetalol; Male; Metoprolol; Physical Exertion; Pindolol; Prazosin; Propranolol; Running | 1984 |
Uptake of L-[propyl-2,3-3H]dihydroalprenolol by intact HeLa cells.
Topics: Adrenergic beta-Antagonists; Alprenolol; Binding, Competitive; Biological Transport; Cell Membrane; Chloroquine; Cold Temperature; Diffusion; Dihydroalprenolol; HeLa Cells; Humans; Hydrogen-Ion Concentration; Isoproterenol; Phentolamine; Pindolol; Receptors, Adrenergic, beta; Valinomycin | 1984 |
A comparison of the binding characteristics of the beta-adrenoceptor antagonists 3H-dihydroalprenolol and 125I-iodocyanopindolol in rat liver.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Binding, Competitive; Dihydroalprenolol; In Vitro Techniques; Iodocyanopindolol; Isoproterenol; Kinetics; Liver; Liver Regeneration; Male; Membranes; Pindolol; Prazosin; Rats; Rats, Inbred Strains | 1984 |
Estimation of cardiodepressant potency of nadolol, alprenolol, propranolol and pindolol, beta-blocking agents, in heart-lung preparation and blood-perfused excised papillary muscle preparation of the dog.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Anti-Arrhythmia Agents; Dogs; Heart; Heart Rate; In Vitro Techniques; Myocardial Contraction; Nadolol; Papillary Muscles; Pindolol; Propanolamines; Propranolol | 1984 |
Beta-adrenergic receptors in ciliary processes of the rabbit.
Topics: Adenylyl Cyclases; Alprenolol; Animals; Cell Membrane; Ciliary Body; Epinephrine; Isoproterenol; Male; Phentolamine; Pindolol; Propranolol; Rabbits; Receptors, Adrenergic; Receptors, Adrenergic, beta; Timolol | 1980 |
Anti-alprenolol antibodies in the rabbit. A new probe for the study of beta-adrenergic receptor interaction.
Topics: Alprenolol; Animals; Antibodies; Antibody Affinity; Benzyl Alcohols; Binding Sites, Antibody; Binding, Competitive; Chemical Fractionation; Immune Sera; Immunosorbent Techniques; Pindolol; Propranolol; Rabbits; Receptors, Adrenergic; Receptors, Adrenergic, beta | 1980 |
Neonatal rat pinealocytes: typical and atypical characteristics of [125I]iodohydroxybenzylpindolol binding and adenosine 3',5'-monophosphate accumulation.
Topics: Alprenolol; Animals; Animals, Newborn; Butoxamine; Cyclic AMP; Epinephrine; In Vitro Techniques; Isoproterenol; Kinetics; Norepinephrine; Oxprenolol; Phenylephrine; Pindolol; Pineal Gland; Propranolol; Rats; Receptors, Adrenergic; Receptors, Adrenergic, beta | 1981 |
The effect of bromoacetylalprenololmentane on rat atrial tension development and beta-adrenoreceptors.
Topics: Alprenolol; Animals; In Vitro Techniques; Iodocyanopindolol; Isoproterenol; Kinetics; Male; Myocardial Contraction; Pindolol; Rats; Rats, Inbred Strains; Receptors, Adrenergic, beta | 1984 |
Delay of onset of second degree pacemaker block by beta-blockade in patients with P-synchronous pacemakers.
Topics: Adult; Aged; Alprenolol; Coronary Disease; Exercise Test; Female; Heart Rate; Humans; Male; Middle Aged; Pacemaker, Artificial; Pindolol | 1981 |
Physiological effects of inverse agonists in transgenic mice with myocardial overexpression of the beta 2-adrenoceptor.
Topics: Adrenergic beta-Agonists; Alprenolol; Animals; Cyclohexane Monoterpenes; GTP-Binding Proteins; Heart; Mice; Mice, Transgenic; Myocardium; Pindolol; Propanolamines; Receptors, Adrenergic, beta | 1995 |
Toxicity of beta-blockers in a rat whole embryo culture: concentration-response relationships and tissue concentrations.
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Animals; Atenolol; Dose-Response Relationship, Drug; Embryo, Mammalian; Embryonic and Fetal Development; In Vitro Techniques; Metoprolol; Pindolol; Propranolol; Rats; Rats, Wistar | 1994 |
Characterization of cardiac beta-adrenergic receptors in the guinea pig heart: application to study of beta-adrenergic receptors in shock models.
Topics: Alprenolol; Animals; Binding, Competitive; Burns; Cell Membrane; Filtration; Guanylyl Imidodiphosphate; Guinea Pigs; Iodine Radioisotopes; Iodocyanopindolol; Isoproterenol; Male; Myocardium; Pindolol; Receptors, Adrenergic, beta; Shock | 1993 |
Antagonism of the stimulus effects of yohimbine and 8-hydroxydipropylaminotetralin.
Topics: 8-Hydroxy-2-(di-n-propylamino)tetralin; Alprenolol; Animals; Cerebral Cortex; Discrimination, Psychological; Hippocampus; Male; Pindolol; Piperazines; Radioligand Assay; Rats; Rats, Inbred F344; Receptors, Adrenergic, alpha; Serotonin; Serotonin Antagonists; Yohimbine | 1993 |
Relationship between desensitization and downregulation of beta-adrenoceptors in cardiac tissues after prolonged in vivo infusion of T-0509, a beta 1-adrenoceptor agonist.
Topics: Adenylyl Cyclases; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Alprenolol; Analysis of Variance; Animals; Binding, Competitive; Down-Regulation; Drug Interactions; Ethanolamines; GTP-Binding Proteins; Heart; Heart Ventricles; Injections, Subcutaneous; Iodocyanopindolol; Isoproterenol; Male; Myocardium; Pindolol; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, beta-2 | 1997 |
Evaluation of the immobilized artificial membrane phosphatidylcholine. Drug discovery column for high-performance liquid chromatographic screening of drug-membrane interactions.
Topics: Acebutolol; Acetonitriles; Adrenergic beta-Antagonists; Alprenolol; Aniline Compounds; Atenolol; Chromatography, High Pressure Liquid; Hydrogen-Ion Concentration; Membranes, Artificial; Metoprolol; Models, Chemical; Osmolar Concentration; Oxprenolol; Phosphatidylcholines; Pindolol; Propranolol; Reproducibility of Results; Timolol | 1998 |
In vitro permeability of eight beta-blockers through Caco-2 monolayers utilizing liquid chromatography/electrospray ionization mass spectrometry.
Topics: Acebutolol; Adrenergic beta-Antagonists; Alprenolol; Atenolol; Biological Availability; Caco-2 Cells; Cell Membrane Permeability; Chromatography, Liquid; Epithelial Cells; Humans; Intestinal Absorption; Intestinal Mucosa; Mass Spectrometry; Metoprolol; Molecular Structure; Oxprenolol; Pindolol; Propranolol; Research Design; Timolol | 1998 |
Functional properties of atypical beta-adrenoceptors on the guinea pig duodenum.
Topics: Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Albuterol; Alprenolol; Animals; Bupranolol; Carteolol; Clenbuterol; Dobutamine; Dopamine; Dose-Response Relationship, Drug; Duodenum; Epinephrine; Ethanolamines; Fenoterol; Guinea Pigs; In Vitro Techniques; Isoproterenol; Male; Muscle Relaxation; Nadolol; Norepinephrine; Phenylephrine; Pindolol; Propanolamines; Propranolol; Receptors, Adrenergic, beta; Stereoisomerism | 2001 |
Restricted access media-molecularly imprinted polymer for propranolol and its application to direct injection analysis of beta-blockers in biological fluids.
Topics: Adrenergic beta-Antagonists; Alprenolol; Animals; Chromatography, High Pressure Liquid; Flow Injection Analysis; Humans; Pindolol; Polymers; Propranolol; Rats; Sensitivity and Specificity | 2003 |
ALpha1-adrenoceptor antagonist properties of CGP 12177A and other beta-adrenoceptor ligands: evidence against beta(3)- or atypical beta-adrenoceptors in rat aorta.
Topics: 15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; Adrenergic alpha-1 Receptor Antagonists; Adrenergic beta-Antagonists; Alprenolol; Animals; Aorta, Thoracic; Binding Sites; Bupranolol; Cell Membrane; Cerebral Cortex; Dose-Response Relationship, Drug; Ethanolamines; Imidazoles; Male; Muscle, Smooth, Vascular; Phenylephrine; Pindolol; Prazosin; Propanolamines; Propranolol; Radioligand Assay; Rats; Rats, Wistar; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, beta-3; Tritium; United Kingdom; Vasoconstriction | 2004 |
Use of vancomycin chiral stationary phase for the enantiomeric resolution of basic and acidic compounds by nano-liquid chromatography.
Topics: Adrenergic beta-Antagonists; Alprenolol; Atenolol; Chromatography, Liquid; Metoprolol; Nanotechnology; Pharmaceutical Preparations; Pindolol; Stereoisomerism; Vancomycin | 2005 |
Low-affinity state beta1-adrenoceptor-induced vasodilation in SHR.
Topics: Adrenergic beta-1 Receptor Agonists; Alprenolol; Animals; Aorta; Blood Pressure; Dose-Response Relationship, Drug; Enalapril; Losartan; Male; Muscle Relaxation; Pindolol; Propanolamines; Rats; Rats, Inbred SHR; Rats, Inbred WKY; Receptors, Adrenergic, beta-1; Vasodilation | 2005 |
Effects of alcohols on CE enantioseparation of basic drugs with native gamma-CD as chiral selector.
Topics: 2-Propanol; Alprenolol; Electrophoresis, Capillary; Ethanol; gamma-Cyclodextrins; Hydrophobic and Hydrophilic Interactions; Isoxsuprine; Methanol; Pindolol; Propranolol; Ritodrine; Sensitivity and Specificity; Stereoisomerism | 2008 |
Preparation and evaluation of propranolol molecularly imprinted solid-phase microextraction fiber for trace analysis of beta-blockers in urine and plasma samples.
Topics: Adrenergic beta-Antagonists; Adsorption; Alprenolol; Atenolol; Chromatography, High Pressure Liquid; Humans; Molecular Imprinting; Pindolol; Polymers; Propranolol; Reproducibility of Results; Sensitivity and Specificity; Solid Phase Microextraction | 2009 |
1H and 13C NMR characteristics of β-blockers.
Topics: Acebutolol; Acids; Adrenergic beta-Antagonists; Alkalies; Alprenolol; Atenolol; Carbazoles; Carbon Isotopes; Carvedilol; Nuclear Magnetic Resonance, Biomolecular; Pindolol; Propanolamines; Propranolol; Protons; Timolol | 2011 |
Kinetic capillary electrophoresis with mass-spectrometry detection (KCE-MS) facilitates label-free solution-based kinetic analysis of protein-small molecule binding.
Topics: Alprenolol; Electrophoresis, Capillary; Kinetics; Labetalol; Mass Spectrometry; Orosomucoid; Pindolol; Propranolol; Protein Binding; Proteins; Small Molecule Libraries | 2011 |